2024-05-28 ã«ãªãã©ã«ãã¢å€§åŠæ ¡ã¢ãŒãã€ã³æ ¡(UCI)
âNature Immunologyã«çºè¡šããããã®ç 究ã¯ããµãŒã«ãã£ã¢ã³ãªãºã ãå ç«èª¿ç¯ãè «ççºçã®é¢ä¿ã解æããå人ã®äœå æèšã«åºã¥ãæéæé©åæ²»çã®æ°ããªå¯èœæ§ã瀺ããŠããŸããç 究ã§ã¯ãã³ãã³çã¢ãã«ãçšããäœå æèšãT现èã®æŽ»æ§åãæå¶ããããšãã€ã现èã®æ°ãå¶åŸ¡ããããšãçºèŠããŸããããŸããå ç«çæ³ãããšãã€ã现èãæãå€ãæé垯ã«æäŸããããšã§ãæ²»çå¹æãå€§å¹ ã«åäžããããšã確èªããŸããã
âãã®çºèŠã¯ãäœå ãªãºã ã掻çšããããåå¥åãããå¹æçãªæ²»çæŠç¥ã®éçºã«è²¢ç®ããŸããç 究ã¯ãåœç«ããç 究æãV財å£ããžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ãªã©ã®æ¯æŽãåããŠããŸãã
<é¢é£æ å ±>
- https://news.uci.edu/2024/05/28/uc-irvine-study-reveals-circadian-clock-can-be-leveraged-to-enhance-cancer-immunotherapy/
- https://www.nature.com/articles/s41590-024-01859-0
è «çå ç«æå¶ã®æŠæ¥å¶åŸ¡ãå ç«ãã§ãã¯ãã€ã³ãé»å®³è¬ã®æå¹æ§ã«åœ±é¿ãã Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade
Bridget M. Fortin,Shannon M. Pfeiffer,Jacob Insua-RodrÃguez,Hamad Alshetaiwi,Alexander Moshensky,Wei A. Song,Alisa L. Mahieu,Sung Kook Chun,Amber N. Lewis,Alex Hsu,Isam Adam,Oliver S. Eng,Nicholas R. Pannunzio,Marcus M. Seldin,Ivan Marazzi,Francesco Marangoni,Devon A. Lawson,Kai Kessenbrock & Selma Masri
Nature Immunology Published:28 May 2024
DOI:https://doi.org/10.1038/s41590-024-01859-0
Abstract
The circadian clock is a critical regulator of immunity, and this circadian control of immune modulation has an essential function in host defense and tumor immunosurveillance. Here we use a single-cell RNA sequencing approach and a genetic model of colorectal cancer to identify clock-dependent changes to the immune landscape that control the abundance of immunosuppressive cells and consequent suppression of cytotoxic CD8+ T cells. Of these immunosuppressive cell types, PD-L1-expressing myeloid-derived suppressor cells (MDSCs) peak in abundance in a rhythmic manner. Disruption of the epithelial cell clock regulates the secretion of cytokines that promote heightened inflammation, recruitment of neutrophils and the subsequent development of MDSCs. We also show that time-of-day anti-PD-L1 delivery is most effective when synchronized with the abundance of immunosuppressive MDSCs. Collectively, these data indicate that circadian gating of tumor immunosuppression informs the timing and efficacy of immune checkpoint inhibitors.
